about
Exploring the Secretomes of Microbes and Microbial Communities Using Filamentous Phage DisplayVitamin B12 as a modulator of gut microbial ecologyEndless Resistance. Endless Antibiotics?Computational approaches to natural product discoveryFunctional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonistMinimum Information about a Biosynthetic Gene cluster.Actinoramide A Identified as a Potent Antimalarial from Titration-Based Screening of Marine Natural Product ExtractsMetagenomic discovery of novel enzymes and biosurfactants in a slaughterhouse biofilm microbial community.Discovery of MRSA active antibiotics using primary sequence from the human microbiome.Natural product discovery from the human microbiome.Reinvigorating natural product combinatorial biosynthesis with synthetic biologyGenetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.Mining prokaryotes for antimicrobial compounds: from diversity to function.RecET direct cloning and Redαβ recombineering of biosynthetic gene clusters, large operons or single genes for heterologous expression.Filamentous fungi from extreme environments as a promising source of novel bioactive secondary metabolitesNatural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive AgentsGenerate a bioactive natural product library by mining bacterial cytochrome P450 patterns.Actinomycetes: still a source of novel antibiotics.In silico methods for linking genes and secondary metabolites: The way forward.ExoCET: exonuclease in vitro assembly combined with RecET recombination for highly efficient direct DNA cloning from complex genomes.Unique amalgamation of primary and secondary structural elements transform peptaibols into potent bioactive cell-penetrating peptides.An Optimized Synthetic-Bioinformatic Natural Product Antibiotic Sterilizes Multidrug-Resistant Acinetobacter baumannii-Infected Wounds.Strategies to diversify natural products for drug discovery.Concepts and Methods to Access Novel Antibiotics from Actinomycetes.
P2860
Q26752545-EF38D24B-1A96-449D-9D67-7EE85AA8190DQ26865694-37AB26CE-A703-4374-89BC-F69CBDB5290DQ28822179-486D67A4-09A6-456A-A1D0-2FECEB013A39Q28830157-FC10B365-008A-45E1-8C03-F72A9DC8B95CQ35748377-0AD0A09F-BEC7-4576-94D5-91ED8251FCD4Q35748739-529614CC-3EB4-4786-A5CA-398FE21A7CC6Q35806286-76D0309D-6677-440B-A71B-6B637476CCE4Q36043538-737A07C3-3232-4994-ABC8-11148F30367AQ36164942-97CC39E7-50B1-4EC9-B313-ACBDB1CAFFDBQ36340566-F5282C0D-8352-4838-AA9D-B534F9DCE8E0Q36590659-D8E3A2C1-E48D-423D-BCE0-9F9358064B05Q38585753-FD224739-7F98-4B54-A089-6B17CB2C7E87Q38840658-5A2040B2-1B30-49F6-87AD-92DF9E3ED1FDQ40648473-993A8BA8-A04B-4B83-B80E-9AB19687C33DQ42582333-AAF8A6F8-AE33-454A-9144-7544940951A5Q42755952-A2DEFB4A-BA3D-4F16-9376-061B5D07CEABQ45269243-72C1862F-0395-4DF0-B732-5D50E6EE17ACQ46319269-38F8A128-865D-4AEC-8241-C0B702E78079Q47138590-EF9F900C-E0D9-476E-93F3-5BB0470B020EQ47309964-1686E901-B622-4E83-B44C-9874C4D8FEBCQ47713355-E1183A99-5AB8-413B-982C-16F9FF3737C7Q48102108-41725097-1E51-4023-9EAD-3B64F9FF5E00Q48138855-B95304D6-78C7-47A1-8964-F3A8955017FDQ55404741-322442CF-939E-43A4-B24F-2910178C5539
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metagenomic small molecule discovery methods.
@ast
Metagenomic small molecule discovery methods.
@en
Metagenomic small molecule discovery methods.
@nl
type
label
Metagenomic small molecule discovery methods.
@ast
Metagenomic small molecule discovery methods.
@en
Metagenomic small molecule discovery methods.
@nl
prefLabel
Metagenomic small molecule discovery methods.
@ast
Metagenomic small molecule discovery methods.
@en
Metagenomic small molecule discovery methods.
@nl
P2860
P1476
Metagenomic small molecule discovery methods.
@en
P2093
Aleksandr Milshteyn
Sean F Brady
P2860
P356
10.1016/J.MIB.2014.05.021
P577
2014-06-01T00:00:00Z